Wade MR: Difference between revisions
From Bioblast
No edit summary |
No edit summary |
||
| Line 2: | Line 2: | ||
|lastname=Wade | |lastname=Wade | ||
|firstname=Mark | |firstname=Mark | ||
|institution=Eli Lilly and Co. | |||
Lilly Corporate Center/DC0545 | |||
|address=893 S Deleware | |||
|area code=46285 | |||
|city=Indianapolis | |city=Indianapolis | ||
|state=Indiana (IN) | |state=Indiana (IN) | ||
| Line 8: | Line 13: | ||
}} | }} | ||
{{Labelingperson}} | {{Labelingperson}} | ||
== Participated at== | == Participated at== | ||
* [[IOC104]] | * [[IOC104]] | ||
Revision as of 14:29, 6 August 2015
| Name | Wade Mark, |
|---|---|
| Institution | Eli Lilly and Co.
Lilly Corporate Center/DC0545 |
| Address | 893 S Deleware, 46285 |
| City | Indianapolis |
| State/Province | Indiana (IN) |
| Country | USA |
| wade_mark_robert@lilly.com | |
| Weblink | |
| O2k-Network Lab | US IN Indianapolis Brozinick JT |
Labels:
Publications
Add references to your publications
